A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet
Status:
Completed
Trial end date:
2002-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy and safety of topiramate compared with
placebo in obese, Type 2 diabetic patients on a controlled diet.
Phase:
Phase 3
Details
Lead Sponsor:
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.